查找临床试验
已按「戈谢病」检索，对应国际通用词 Gaucher disease
共找到 25 项正在招募的试验
数据更新于 00:19，每 5 分钟自动同步An Exploratory Clinical Trial of VGN-R08b in Patients With Type II Gaucher Disease
China
年龄 0 Months – 24 Months
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Oxidative Stress and Inflammatory Biomarkers in Gaucher Disease
United States
年龄 18 Years – 75 Years
University of Minnesota
Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
United States
年龄 2 Months – 55 Years
Paul Szabolcs
A Study of the Safety and Preliminary Efficacy of LY-M001 Injection in the Treatment of Adult Patients With Gaucher Disease Type I
China
年龄 18 Years – 60 Years
He Huang
Gaucherite - A Study to Stratify Gaucher Disease
United Kingdom
年龄 不限 – 不限
Cambridge University Hospitals NHS Foundation Trust
A Clinical Study Evaluating LY-M001 Injection in the Treatment of Adult Patients With Type I Gaucher Disease
China
年龄 18 Years – 60 Years
Lingyi Biotech Co., Ltd.
A Long-term Follow-up Study of Gaucher Disease
United States
年龄 不限 – 不限
Duke University
Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma
United States
年龄 18 Months – 不限
UNC Lineberger Comprehensive Cancer Center
Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
United States
年龄 2 Months – 60 Years
Paul Szabolcs
GammaGA: Prevalence of Acid Sphingomyelinase Deficiency Disease (ASMD) and Gaucher Disease in Patients With Monoclonal Gammopathies and/or Multiple Myeloma
Spain
年龄 18 Years – 99 Years
Fundación Española de Hematología y Hemoterapía
A Gaucher Disease Gene Therapy Trial With FLT201
United States、Argentina、Australia、Brazil、Canada 等 10 国
年龄 18 Years – 不限
Spur Therapeutics
MAGNETIC RESONANCE SPECTROSCOPY BIOMARKERS IN TYPE 3 GAUCHER DISEASE (GD3)
United States
年龄 18 Years – 80 Years
University of Minnesota